We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $16.7M
1-Year Est. Return 119.35%
This Fund
S&P 500
This Quarter Est. Return
+5.11%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$431M
AUM Growth
+$57.9M
Cap. Flow
+$49.2M
Cap. Flow %
11.43%
Top 10 Hldgs %
70.63%
Holding
40
New
7
Increased
4
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
WT icon
WisdomTree
WT
+$25.8M
2
CHRD icon
Chord Energy
CHRD
+$17.3M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$12.7M
4
OPTU
Optimum Communications Inc
OPTU
+$12M
5
PDCE
PDC Energy, Inc.
PDCE
+$8.07M

Top Sells

Rank Stock Value
1
CPE
Callon Petroleum Company
CPE
+$24.9M
2
TGTX icon
TG Therapeutics
TGTX
+$22M
3
NFYS.U
Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFYS.U
+$12.2M
4
ARNC
Arconic Corporation
ARNC
+$11.1M
5
CIVI
Civitas Resources
CIVI
+$8.45M

Sector Composition

Rank Sector Weight
1 Healthcare 19.17%
2 Energy 13.64%
3 Technology 8.6%
4 Financials 6.16%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
26
Enliven Therapeutics
ELVN
$3.92B
$1.57M 0.36%
+208,695
New +$1.38M
INVZ icon
27
Innoviz Technologies
INVZ
$95M
$1.45M 0.34%
400,000
– –
SYRE icon
28
Spyre Therapeutics
SYRE
$8.54B
$690K 0.16%
12,000
– –
ORGN
29
DELISTED
Origin Materials
ORGN
$658K 0.15%
3,333
– –
IBM icon
30
IBM
IBM
$211B
$650K 0.15%
+5,000
New +$652K
LUMO
31
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$481K 0.11%
51,205
– –
SDIG
32
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$117K 0.03%
2,000
– –
AA icon
33
Alcoa
AA
$11.9B
$90K 0.02%
1,000
– –
SCOR icon
34
Comscore
SCOR
$106M
$2K ﹤0.01%
50
– –
LBTYA icon
35
Liberty Global Class A
LBTYA
$3.62B
– –
-100,000
Closed -$2.77M
TGTX icon
36
TG Therapeutics
TGTX
$7.96B
– –
-1,160,307
Closed -$22M
NFYS.U
37
DELISTED
Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFYS.U
– –
-1,225,000
Closed -$12.2M
CPE
38
DELISTED
Callon Petroleum Company
CPE
– –
-527,538
Closed -$24.9M
CTXS
39
CALL
DELISTED
Citrix Systems Inc
CTXS
– –
-279,800
Closed -$26.5M
1
2

Similar funds

PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return
B
BP London, United Kingdom $17.7M AUM 12.34% 1-Year Est. Return
BCPE
Bain Capital Public Equity Boston, Massachusetts $18M AUM 35.19% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return

Lion Point Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Lion Point Capital held 40 positions worth $431M, up 16% from $373M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Lion Point Capital deployed $49.2M of net new capital in Q1 2022, opening 7 new positions and adding to 4 existing holdings. Its largest new stake was WisdomTree: 4,521,979 shares worth $26.5M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 22% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Arconic Corporation, an estimated $11.1M trimmed.

  • Lion Point Capital's largest Q1 2022 buy was WisdomTree: 4,521,979 shares worth $26.5M.
  • Lion Point Capital added most to Chord Energy in Q1 2022, an estimated $17.3M increase.
  • Lion Point Capital's biggest Q1 2022 reduction was Arconic Corporation, cutting an estimated $11.1M.
  • Lion Point Capital fully exited Callon Petroleum Company in Q1 2022, selling an estimated $24.9M.
  • Lion Point Capital's ten largest holdings make up 71% of its $431M portfolio in Q1 2022.
  • Lion Point Capital opened 7 new positions and closed 5 in Q1 2022.
  • Lion Point Capital's portfolio value rose 16% quarter-over-quarter to $431M.

Based on Lion Point Capital's 13F filing for Q1 2022, filed 16 May 2022.